Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,409 | 111 | 70.7% |
| Consulting Fee | $1,000 | 1 | 29.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,084 | 51 | $0 (2024) |
| The Institute of Musculoskeletal Science and Education | $1,000 | 1 | $0 (2019) |
| Janssen Biotech, Inc. | $324.05 | 12 | $0 (2024) |
| Merck Sharp & Dohme LLC | $189.65 | 10 | $0 (2024) |
| Gilead Sciences, Inc. | $129.06 | 8 | $0 (2024) |
| Camber Spine Technologies | $118.11 | 1 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $115.95 | 7 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $99.95 | 4 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $74.83 | 3 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $60.09 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $903.01 | 39 | ABBVIE INC. ($364.92) |
| 2023 | $479.07 | 23 | AbbVie Inc. ($270.18) |
| 2022 | $313.42 | 12 | ABBVIE INC. ($278.85) |
| 2019 | $1,118 | 2 | The Institute of Musculoskeletal Science and Education ($1,000) |
| 2018 | $195.58 | 12 | Takeda Pharmaceuticals U.S.A., Inc. ($72.42) |
| 2017 | $399.44 | 24 | AbbVie, Inc. ($134.06) |
All Payment Transactions
112 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $37.42 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $29.80 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $30.15 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $34.34 | General |
| Category: Immunology | ||||||
| 09/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 09/10/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/10/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.62 | General |
| 09/05/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $32.34 | General |
| Category: IMMUNOLOGY | ||||||
| 08/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Gastroenterology | ||||||
| 08/24/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.32 | General |
| 08/22/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $30.44 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/15/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 08/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.17 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/01/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 07/24/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: IMMUNOLOGY | ||||||
| 06/13/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/28/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 276 | 281 | $129,357 | $30,677 |
| 2022 | 10 | 330 | 338 | $161,291 | $40,706 |
| 2021 | 10 | 377 | 392 | $171,145 | $43,132 |
| 2020 | 18 | 952 | 999 | $269,358 | $73,698 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 65 | 65 | $46,807 | $12,781 | 27.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 79 | 80 | $31,205 | $6,489 | 20.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 23 | 24 | $12,432 | $3,125 | 25.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 18 | 18 | $10,226 | $1,915 | 18.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 25 | 25 | $8,566 | $1,890 | 22.1% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 18 | 18 | $7,836 | $1,821 | 23.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 13 | $3,614 | $898.32 | 24.9% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 12 | 12 | $3,264 | $761.88 | 23.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 13 | $2,462 | $603.38 | 24.5% |
| 43450 | Dilation of esophagus | Facility | 2023 | 12 | 13 | $2,946 | $391.43 | 13.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 94 | 94 | $64,350 | $17,631 | 27.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 81 | 84 | $31,264 | $6,319 | 20.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 29 | 29 | $15,729 | $2,944 | 18.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 16 | 16 | $7,970 | $2,730 | 34.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 22 | 22 | $10,991 | $2,706 | 24.6% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 24 | 25 | $10,324 | $2,567 | 24.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 13 | 13 | $6,478 | $2,292 | 35.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 20 | $5,423 | $1,476 | 27.2% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 15 | 16 | $5,300 | $1,264 | 23.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 19 | $3,463 | $777.37 | 22.5% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 88 | 89 | $61,886 | $16,858 | 27.2% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 116 | 123 | $46,373 | $10,094 | 21.8% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 27 | 27 | $14,877 | $3,071 | 20.6% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 17 | 20 | $10,216 | $2,876 | 28.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 13 | 13 | $6,554 | $2,337 | 35.7% |
About Benjamin Stein, M.D.,
Benjamin Stein, M.D., is a Gastroenterology healthcare provider based in Lewiston, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2008. The National Provider Identifier (NPI) number assigned to this provider is 1245402460.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Benjamin Stein, M.D., has received a total of $3,409 in payments from pharmaceutical and medical device companies, with $903.01 received in 2024. These payments were reported across 112 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($2,409).
As a Medicare-enrolled provider, Stein has provided services to 1,935 Medicare beneficiaries, totaling 2,010 services with total Medicare billing of $188,212. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Lewiston, ME
- Active Since 03/27/2008
- Last Updated 11/24/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1245402460
Products in Payments
- Spira (Device) $1,000
- SKYRIZI (Biological) $417.25
- STELARA (Biological) $252.29
- DIFICID (Drug) $189.65
- RINVOQ (Biological) $187.60
- LINZESS (Drug) $159.56
- CREON (Drug) $103.33
- Humira (Biological) $101.90
- XIFAXAN (Drug) $99.95
- DUPIXENT (Biological) $99.65
- VIBERZI (Drug) $87.85
- Amitiza (Drug) $84.55
- OCALIVA (Drug) $74.83
- TREMFYA (Drug) $71.76
- Creon (Drug) $67.69
- VOQUEZNA (Drug) $47.05
- GATTEX (Drug) $43.53
- Cimzia (Drug) $34.33
- UCERIS (Drug) $19.64
- Entyvio (Biological) $19.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Lewiston
Dr. Oswaldo Bisbal, Md, MD
Gastroenterology — Payments: $3,688
Emil Miskovsky, Md, MD
Gastroenterology — Payments: $2,859
Dr. Winoah Henry, M.d, M.D
Gastroenterology — Payments: $1,659
Catherine Mccrann, Md, MD
Gastroenterology — Payments: $910.59
Dr. Mark Branda, Md, MD
Gastroenterology — Payments: $559.13
Lee Hixson, M.d, M.D
Gastroenterology — Payments: $314.22